| CXSL2200317 | 德谷胰岛素注射液 | insulin degludec | Injection | Biological Products(3.3) | New Drug Application | 2022-07-14 | | Hangzhou Zhongmei Huadong Pharmaceutical Co Ltd | | | view |
| CXSL2300092 | 德谷胰岛素利拉鲁肽注射液 | insulin degludec;liraglutide | Injection | Biological Products(3.3) | New Drug Application | 2023-02-08 | | The United Bio-Technology(Hengqin) Co Ltd | | | view |
| CYSB2101269 | 德谷胰岛素注射液 | insulin degludec | Injection | Biological Products | Supplementary Application | 2021-11-10 | | Novo Nordisk (China) Pharmaceuticals Co Ltd | | | view |
| CXSL2400105 | 德谷胰岛素利拉鲁肽注射液 | insulin degludec;liraglutide | Injection | Biological Products(3.3) | New Drug Application | 2024-02-07 | | Tonghua Dongbao Pharmaceutical Co Ltd | | | view |
| CXSS2400110 | 德谷胰岛素注射液 | insulin degludec | Injection | Biological Products(3.3) | New Drug Application | 2024-10-12 | | Zhuhai Federal Biomedical Co Ltd | | | view |
| CXSL2101158 | 德谷胰岛素注射液 | insulin degludec | Injection | Biological Products(3.3) | New Drug Application | 2021-06-29 | | Beijing SL Pharmaceutical Co Ltd | | | view |
| CXSL2200318 | 德谷胰岛素注射液 | insulin degludec | Injection | Biological Products(3.3) | New Drug Application | 2022-07-25 | | Tonghua Dongbao Pharmaceutical Co Ltd | | | view |
| JYSB2101153 | 德谷胰岛素注射液 | insulin degludec | Injection | Biological Products | Supplementary Application | 2021-10-22 | | Novo Nordisk A/S | | | view |
| CYSB2300007 | 德谷胰岛素利拉鲁肽注射液 | insulin degludec;liraglutide | Injection | Biological Products | Supplementary Application | 2023-01-11 | | Novo Nordisk (China) Pharmaceuticals Co Ltd | | | view |
| JYSB2500112 | 德谷胰岛素利拉鲁肽注射液 | insulin degludec;liraglutide | Injection | Biological Products | Supplementary Application | 2025-05-01 | | Novo Nordisk A/S | | | view |
| CXSL2400082 | 德谷胰岛素利拉鲁肽注射液 | insulin degludec;liraglutide | Injection | Biological Products(3.3) | New Drug Application | 2024-02-01 | | Dongguan HEC Biopharmaceutical R&D Co Ltd;Sunshine Lake Pharma Co Ltd | | | view |
| CYSB2101172 | 德谷胰岛素注射液 | insulin degludec | Injection | Biological Products | Supplementary Application | 2021-08-31 | | Novo Nordisk (China) Pharmaceuticals Co Ltd | | | view |
| CXSS2400109 | 德谷胰岛素注射液 | insulin degludec | Injection | Biological Products(3.3) | New Drug Application | 2024-10-12 | | Zhuhai Federal Biomedical Co Ltd | | | view |
| JYSB2101167 | 德谷胰岛素注射液 | insulin degludec | Injection | Biological Products | Supplementary Application | 2021-11-10 | | Novo Nordisk A/S | | | view |
| CXSS2200066 | 德谷胰岛素注射液 | insulin degludec | Injection | Biological Products(3.3) | New Drug Application | 2022-07-15 | | Jilin Huisheng Biopharmaceutical Co Ltd | | | view |
| JYSB2101166 | 德谷胰岛素注射液 | insulin degludec | Injection | Biological Products | Supplementary Application | 2021-11-10 | | Novo Nordisk A/S | | | view |
| CXSL2200411 | 德谷胰岛素利拉鲁肽注射液 | insulin degludec;liraglutide | Injection | Biological Products(3.3) | New Drug Application | 2022-08-29 | | Tonghua Dongbao Pharmaceutical Co Ltd | | | view |
| CXSS2500030 | 德谷胰岛素注射液 | insulin degludec | Injection | Biological Products(3.3) | New Drug Application | 2025-02-20 | | Hangzhou Zhongmei Huadong Pharmaceutical Co Ltd | | | view |
| JYSB2400021 | 德谷胰岛素利拉鲁肽注射液 | insulin degludec;liraglutide | Injection | Biological Products | Supplementary Application | 2024-02-01 | | Novo Nordisk A/S | | | view |
| JYSZ2200008 | 德谷胰岛素注射液 | insulin degludec | Injection | Biological Products | License Renew | 2022-03-04 | | Novo Nordisk A/S | | | view |
